SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is conducting a thorough investigation into possible violations of securities laws by specific officers at Sprout Social, Inc. (NASDAQ: SPT), Altimmune, Inc. (NASDAQ: ALT), Equinix, Inc. (NASDAQ: EQIX), and Globe Life Inc. (NYSE: GL). Shareholders are encouraged to review additional information by following the links below:
Sprout Social, Inc: Click Here to Join
Altimmune, Inc: Click Here to Join
Equinix, Inc: Click Here to Join
Globe Life, Inc: Click Here to Join
Johnson Fistel is currently undertaking an extensive investigation related to potential violations of shareholder rights involving certain companies that are facing securities class action lawsuits.
If warranted our firm is prepared to commence a derivative lawsuit on behalf of shareholders who have made a long-term investment in these companies. A derivative lawsuit is aimed at holding accountable the directors and officers, not the corporations themselves, for any potential violations.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com
